Literature DB >> 23146568

Short chain fatty acids and their receptors: new metabolic targets.

Brian T Layden1, Anthony R Angueira, Michael Brodsky, Vivek Durai, William L Lowe.   

Abstract

Fatty acids are carboxylic acids with aliphatic tails of different lengths, where short chain fatty acids (SCFAs) typically refer to carboxylic acids with aliphatic tails less than 6 carbons. In humans, SCFAs are derived in large part from fermentation of carbohydrates and proteins in the colon. By this process, the host is able to salvage energy from foods that cannot be processed normally in the upper parts of the gastrointestinal tract. In humans, SCFAs are a minor nutrient source, especially for people on Western diets. Intriguingly, recent studies, as highlighted here, have described multiple beneficial roles of SCFAs in the regulation of metabolism. Further interest in SCFAs has emerged due to the association of gut flora composition with obesity and other metabolic states. The recent identification of receptors specifically activated by SCFAs has further increased interest in this area. These receptors, free fatty acid receptor-2 and -3 (FFAR2 and FFAR3), are expressed not only in the gut epithelium where SCFAs are produced, but also at multiple other sites considered to be metabolically important, such as adipose tissue and pancreatic islets. Because of these relatively recent findings, studies examining the role of these receptors, FFAR2 and FFAR3, and their ligands, SCFAs, in metabolism are emerging. This review provides a critical analysis of SCFAs, their recently identified receptors, and their connection to metabolism. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23146568     DOI: 10.1016/j.trsl.2012.10.007

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  87 in total

1.  Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates.

Authors:  Erica D Sonnenburg; Justin L Sonnenburg
Journal:  Cell Metab       Date:  2014-08-21       Impact factor: 27.287

Review 2.  Targeting Innate Immunity for Type 1 Diabetes Prevention.

Authors:  James C Needell; Danny Zipris
Journal:  Curr Diab Rep       Date:  2017-09-27       Impact factor: 4.810

Review 3.  Roles of Probiotic Lactobacilli Inclusion in Helping Piglets Establish Healthy Intestinal Inter-environment for Pathogen Defense.

Authors:  Jiajun Yang; Kun Qian; Chonglong Wang; Yijing Wu
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

Review 4.  Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology.

Authors:  Medha Priyadarshini; Kumar U Kotlo; Pradeep K Dudeja; Brian T Layden
Journal:  Compr Physiol       Date:  2018-06-18       Impact factor: 9.090

Review 5.  Brain-gut microbiome interactions and functional bowel disorders.

Authors:  Emeran A Mayer; Tor Savidge; Robert J Shulman
Journal:  Gastroenterology       Date:  2014-02-28       Impact factor: 22.682

Review 6.  Communicating systems in the body: how microbiota and microglia cooperate.

Authors:  Daniel Erny; Anna Lena Hrabě de Angelis; Marco Prinz
Journal:  Immunology       Date:  2016-08-24       Impact factor: 7.397

7.  The short-chain fatty acid receptor, FFA2, contributes to gestational glucose homeostasis.

Authors:  Miles Fuller; Medha Priyadarshini; Sean M Gibbons; Anthony R Angueira; Michael Brodsky; M Geoffrey Hayes; Petia Kovatcheva-Datchary; Fredrik Bäckhed; Jack A Gilbert; William L Lowe; Brian T Layden
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-09-22       Impact factor: 4.310

8.  Sodium acetate improves disrupted glucoregulation and hepatic triglyceride content in insulin-resistant female rats: involvement of adenosine deaminase and dipeptidyl peptidase-4 activities.

Authors:  Tolulope Eniola Omolekulo; Olugbenga Samuel Michael; Lawrence Aderemi Olatunji
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-02       Impact factor: 3.000

9.  Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity.

Authors:  Alice P Liou; Melissa Paziuk; Jesus-Mario Luevano; Sriram Machineni; Peter J Turnbaugh; Lee M Kaplan
Journal:  Sci Transl Med       Date:  2013-03-27       Impact factor: 17.956

Review 10.  Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Authors:  Ali Ramezani; Ziad A Massy; Björn Meijers; Pieter Evenepoel; Raymond Vanholder; Dominic S Raj
Journal:  Am J Kidney Dis       Date:  2015-11-15       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.